Effects of Nitric Oxide on the Endothelium During Hemolysis.

NCT03748082 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Endothelial Dysfunction
Hemolysis Intravascular
Cardiovascular Diseases
Cardiovascular Risk Factor

Interventions

DRUG: Nitric Oxide
DIAGNOSTIC_TEST: Reactive Hyperemia Index
PROCEDURE: Endothelial Cells Collection

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]